Armistice Capital »

Gaxos.ai shares owned by Armistice Capital

Quarter-by-quarter ownership of Gaxos.ai (GXAI) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Gaxos.ai

Tip: Access up to 7 years of quarterly data

All positions including Gaxos.ai held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gaxos.ai by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $286k 103k 2.78
2024-03-31 $663k 108k 6.14

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Gaxos.ai

Armistice Capital
Tower Research Capital
Bank of America Corporation

View all funds holding Gaxos.ai